Human T Cell Leukemia Virus Type I (HTLV-I)-Specific CD8+ CTL Clones from Patients with HTLV-I-Associated Neurologic Disease Secrete Proinflammatory Cytokines, Chemokines, and Matrix Metalloproteinase

Journal of Immunology

Volumn 159, Issue 4, 1997, Pages 2018-2025

  Biddison, William E ^a,f   Kubota, Ryuji ^a   Kawanishi, Taketo ^a   Taub, Dennis D ^b   Cruikshank, William W ^c   Center, David M ^c   Connor, Edward W ^d   Utz, Ursula ^e   Jacobson, Steven ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b SAIC FREDERICK INC   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^f NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; COLLAGENASE; CYTOKINE; GAMMA INTERFERON; GELATINASE B; HLA A2 ANTIGEN;

ARTICLE; BIOSYNTHESIS; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNOLOGY; SPASTIC PARAPLEGIA;

CHEMOKINES; COLLAGENASES; CYTOKINES; HLA-A2 ANTIGEN; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; INTERFERON TYPE II; MATRIX METALLOPROTEINASE 9; PARAPARESIS, TROPICAL SPASTIC; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0031571256     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.159.4.2018     Document Type: Article

References (50)

1. Roman, G., and M. Osame. 1988. Identity of HTLV-I-associated tropical spastic paraparesis and HTLV-I-associated myelopathy. Lancet i:651.
2. Kuroda, Y., M. Matsui, M. Kikuchi, K. Kirohara, C. Endo, M. Yukitake, Y. Matsuda, O. Tokunaga, A. Komine-Sakaki, and R. Kawaguchi. 1994. In situ demonstration of the HTLV-I genome in the spinal cord of a patient with HTLV-I associated myelopathy. Neurology 44:2295.
3. Lehky, T., C. Fox, S. Koenig, M. Levin, N. Flerlage, S. Izumo, E. Sato, C. Raine, M. Osame, and S. Jacobson. 1995. Detection of human T lymphotropic virus type I (HTLV-I) tax RNA in the central nervous system of HTLV-I associated myelopathy/tropical spastic paraparesis patients by in situ hybridization. Ann. Neurol. 37:246.
4. Moore, G., U. Traugott, L. Schienberg, and C. Raine. 1989. Tropical spastic paraparesis: a model of virus-induced cytotoxic T cell mediated demyelination? Ann. Neurol. 26:523.
5. Umehara, F., S. Izumo, M. Nakagawa, A. Ronquillo, K. Takahashi, K. Matsumuro, E. Sato, and M. Osame. 1993. Immunocytochemical analysis of the cellular infiltrates in the spinal cord lesions in HTLV-I associated myelopathy. J. Neuropathol. Exp. Neurol. 52:424.
6. Wu, E., D. Dickson, S. Jacobson, and C. Raine. 1993. Neuroaxonal dystrophy in HTLV-I associated myelopathy/tropical spastic paraparesis neuropathologic and neuroimmunologic correlations. Acta Neuropathol. 86:224.
7. + lymphocytes in the spinal cord from patients with HTLV-I associated myelopathy. J. Neuroimmunol. 53:23.
8. Iwasaki, I. 1990. Pathology of chronic myelopathy associated with HTLV-I infection (HAM/TSP). J. Neurol. Sci. 96:103.
9. Yoshioka, A., G. Hirose, Y. Ueda, Y. Nishimura, and K. Sakai. 1993. Neuropathological studies of the spinal cord in early stage HTLV-I-associated myelopathy (HAM). J. Neurol. Neurosurg. Psychiatry 56:1004.
10. Jacobson, S. 1992. Immune response to retroviruses in the central nervous system: role in the neuropathology of HTLV-I associated neurologic disease. Semin. Neurosci. 4:285.
11. Umehara, F., A. Nakamura, S. Izumo, R. Kubota, S. Ijichi, N. Kashio, K.-I. Hashimoto, K. Usuku, E. Sato, and M. Osame. 1994. Apoptosis of T lymphocytes in the spinal cord lesions of HTLV-I associated myelopathy: a possible mechanism to control viral infection in the central nervous system. J. Neuropathol. Exp. Neurol. 53:617.
12. Elovaara, I., S. Koenig, A. Brewah, R. Woods, T. Lehky, and S. Jacobson. 1993. High human T-cell lymphotropic virus type I (HTLV-I)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-I-associated neurological disease. J. Exp. Med. 177:1567.
13. + cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature 348:245.
14. Levin, M., T. Lehky, N. Flerlage, D. Katz, D. Kingma, E. Jaffe, J. Heiss, N. Patronas, H. McFarland, and S. Jacobson. 1997. Immunopathogenesis of HTLV-I associated neurologic disease based on a spinal cord biopsy from a patient with HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/ TSP). N. Engl. J. Med. In press.
15. Jacobson, S. 1996. Role of cellular immune responses in the pathogenesis of human T cell lymphotropic virus type I (HTLV-I) associated neurological disease. In Human T Cell Lymphotropic Virus Type I. P. Holsberg and D. Hafler, eds. Wiley & Sons, London, pp. 141-166.
16. Beutler, B., and A. Cerami. 1989. The biology of cachetin/TNF - a primary mediator of the host response. Annu. Rev. Immunol. 7:625.
17. Chin, Y., J. Cai, and K. Johnson 1990. Lymphocyte adhesion to cultured Peyer's patch high endothelial venule cells is mediated by organ-specific homing receptors and can be regulated by cytokines. J. Immunol. 145:3669.
18. Hofman, F., D. Hinton, K. Johnson, and J Merrill. 1989. Tumor necrosis factor identified in multiple sclerosis brain. J. Exp. Med. 170:607.
19. Selmaj, K., C. Raine, M. Farooq, W. Norton, and C. Brosnan. 1991. Cytokine cytotoxicity against oligodendrocytes. J. Immunol. 147:1522.
20. Sethna, M., and L. Lampson. 1991. Immune modulation within the brain: recruitment of inflammatory cells and increased major histocompatibility antigen expression following intracerebral injection of interferon-gamma. J. Neuroimmunol. 34:121.
21. Sharief, M., and R. Hentges. 1992. Association between tumor necrosis factor-α and disease progression in patients with multiple sclerosis. N. Engl. J. Med. 326:272.
22. Sharief, M., and E. Thompson. 1992. In vivo relationship of tumor necrosis factor-α to blood-brain barrier damage in patients with active multiple sclerosis. J. Neuroimmunol. 38:27.
23. Schall, T. 1994. The chemokines. In The Cytokine Handbook. A. Thompson, ed. Academic Press, New York, pp. 419-460.
24. + human peripheral blood lymphocytes are potent sources of macrophage inflammatory 1, protein 1α, interleukin-8, and RANTES. Eur. J. Immunol. 25:751.
25. Cruikshank, W., D. Center, N. Nisar, B. Natke, A. Theodore, and H. Kornfeld. 1994. Molecular and functional analysis of a lymphocyte chemoattractant factor: association of biologic function with CD4 expression. Proc. Natl. Acad. Sci. USA 91:5109.
26. Cruikshank, W., A. Long, R. Tarpy, H. Kornfeld, M. Carroll, L. Teran, S. Holgate, and D. Center. 1995. Early identification of interleukin-16 (lymphocyte chemoattractant factor) and macrophage inflammatory protein 1α (MIP1α) in bronchoalveolar lavage fluid of antigen-challenged asthmatics. Am. J. Respir. Cell Mol. Biol. 13:738.
27. Goetzl, E., M. Banda, and D. Leppert. 1996. Matrix metalloproteinases in immunity. J. Immunol. 156:1.
28. Ries, C., and P. Petrides. 1995. Cytokine regulation of matrix metalloproteinase activity and its regulatory dysfunction in disease. Biol. Chem. Hoppe-Seyler 376: 345.
29. Gearing, A., P. Beckett, M. Christodoulou, M. Churchill, J. Clements, A. Davidson, A. Drummond, W. Galloway, R. Gilbert, J. Gordon, T. Leber, M. Mangan, K. Miller, P. Nayee, K. Owen, S. Patel, W. Thomas, G. Wells, L. Wood, and K. Wooley. 1994. Processing of tumour necrosis factor-alpha precursor by metalloproteinases. Nature 370:555.
30. Sanders, B., J. Andersson, and U. Andersson. 1991. Assessment of cytokines by immunofluorescence and the paraformaldehyde-saponin procedure. Immunol. Rev. 119:65.
31. + cytotoxic T lymphocytes from patients with HTLV-1-associated disease: evidence for oligoclonal expansion. J. Virol. 70:843.
32. Koenig, S., R. Woods, A. Brewah, A. Newell, G. Jones, E. Boone, J. Adelsberger, M. Baseler, S. Robinson, and S. Jacobson. 1993. Characterization of major histocompatibility complex (MHC) class I-restricted cytotoxic T cell responses to Tax in HTLV-I infected patients with neurological disease. J. Immunol. 156: 3874.
33. Utz, U., S. Koenig, J. Coligan, and W. Biddison. 1992. Presentation of three different viral peptides, HTLV-I Tax, HCMV gB, and influenza virus M1 is determined by common structural features of the HLA-A2.1. J. Immunol. 149: 214.
34. Storkus, W., D. Howell, R. Salter, J. Dawson, and P. Cresswell. 1987. NK susceptibility varies inversely with target cell class I HLA expression. J. Immunol. 138:1657.
35. + T cells in response to MIP-1α and MIP-1β. Science 260:355.
36. Kleiner, D., and W. Stetler-Stevenson. 1994. Quantitative zymography: detection of picogram quantities of gelatinases. Anal. Biochem. 218:325.
37. Valitutti, S., S. Muller, M. Dessing, and A. Lanzavecchia. 1996. Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy. J. Exp. Med. 183:1917.
38. Del Pozo, M., P. Sanchez-Mateos, M. Nieto, and F. Sanchez-Madrid. 1995. Chemokines regulate cellular polarization and adhesion receptor redistribution during lymphocyte interaction with endothelium and extracellular matrix: involvement of cAMP signalling pathway. J. Cell Biol. 131:495.
39. Schall, T., K. Bacon, R. Camp, J. Kaspari, and D. Goeddel. 1993. Human macrophage inflammatory protein 1α (MIP-1α) and MIP-1β chemokines attract distinct populations of lymphocytes. J. Exp. Med. 177:1821.
40. + T lymphocytes to intact or heparinase-treated subendothelial extracellular matrix by diffusable or anchored RANTES and MIP-1β. J. Immunol. 153:4899.
41. Lloyd, A., J. Oppenheim, D. Kelvin, and D. Taub. 1996. Chemokines regulate T cell adherence to recombinant adhesion molecules and extracellular matrix proteins. J. Immunol. 156:932.
42. Tanaka, Y., D. Adams, S. Hubscher, H. Hirano, U. Siebenlist, and S. Shaw. 1993. T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1β. Nature 361:79.
43. Miyagishi, R., S. Kikuchi, T. Fukazawa, and K. Tashiro. 1995. Macrophage inflammatory protein-1α in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological diseases. J. Neurol. Sci. 129:223.
44. Swain, S., L. Bradley, M. Croft, S. Tonkonogy, G. Atkins, A. Weinberg, D. Duncan, S. Hedrick, R. Dutton, and G. Huston. 1991. Helper T cell subsets: phenotype, function, and the role of lymphokines in regulating their development. Immunol. Rev. 121:115.
45. Richardson, J., A. Edwards, J. Cruikshank, P. Rudge, and A. Dalgleish. 1990. In vivo cellular tropism of human T-cell leukemia virus type 1. J. Virol. 64:5682.
46. Iwasaki, Y., Y. Ohara, I. Kobayashi, and S. Akizuki. 1992. Infiltration of helper/ inducer T lymphocytes heralds central nervous system damage in human T-cell leukemia virus infection. Am. J. Pathol. 140:1003.
47. Gijbels, K., S. Masure, H. Carton, and G. Opdenakker. 1992. Gelatinase in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disorders. J. Neuroimmunol. 41:29.
48. Gijbels, K., S. Masure, H. Carton, A. Billiau, and G. Opdenakker. 1993. Gelatinase B is present in the cerebrospinal fluid during experimental autoimmune encephalomyelitis and cleaves myelin basic protein. J. Neurosci. Res. 36:432.
49. Gijbels, K., R. Galardy, and L. Steinman. 1994. Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases. J. Clin. Invest. 94:2177.
50. Arden, B., S. Clark, D. Kabelitz, and T. Mak. 1995. Human T-cell receptor variable gene segment families. Immunogenetics 42:455.